Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06640738
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Remifentanil and Dexmedetomidine in Uterine Fibroid Ablation a Comparative Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial aims to find a better drug concentration of Remifentanil in Uterine Fibroid Ablation The main question it seeks to answer is
primary hypothesis 1 Remifentanil concentration of 20 ngmL provides better pain control in Uterine Fibroid Ablation
There is a comparison group in this study Researchers will compare Remifentanil concentration of 10 ngmL to see if provides similar pain control with fewer side effects
Participants will be separated into two groups one group with a Remifentanil concentration of 20 ngmL and the other 10 ngmL During uterine fibroid ablation the patient39s pain index will be recorded using a Visual Analogue Scale VAS of 010 points We will also record vital signs during the procedure
primary hypothesis 1 Remifentanil concentration of 20 ngmL provides better pain control in Uterine Fibroid Ablation
There is a comparison group in this study Researchers will compare Remifentanil concentration of 10 ngmL to see if provides similar pain control with fewer side effects
Participants will be separated into two groups one group with a Remifentanil concentration of 20 ngmL and the other 10 ngmL During uterine fibroid ablation the patient39s pain index will be recorded using a Visual Analogue Scale VAS of 010 points We will also record vital signs during the procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None